Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00231985 · ClinicalTrials.gov registry record · Phase 2

Effectiveness of Behavior Therapy and Psychosocial Therapy for the Treatment of Tourette Syndrome and Chronic Tic Disorder

A Phase 2 study, sponsored by Massachusetts General Hospital.

Completed
Registry status
Phase 2
Development phase
122
Enrollment target

NCT00231985: Completed Phase 2 study, sponsored by Massachusetts General Hospital.

NCT00231985 is a Phase 2 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 122 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00231985, a Phase 2 study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
Phase 2
Development phase
122 participants
Enrollment target

Study Summary

This study will compare the efficacy of supportive therapy versus habit-reversal therapy for the treatment of Tourette syndrome and chronic tic disorder.

Interventions

  • BEHAVIORAL Supportive therapy
  • BEHAVIORAL Habit reversal therapy

Trial Details

FieldValue
Enrollment Target 122 participants
Start Date 2005-10
Est. Completion 2010-03
Phase Phase 2

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT00231985

The ClinicalTrials.gov registry entry for NCT00231985 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Supportive therapy is the first listed.

NCT00231985 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00231985 about?

NCT00231985 is a clinical study titled "Effectiveness of Behavior Therapy and Psychosocial Therapy for the Treatment of Tourette Syndrome and Chronic Tic Disorder". This study will compare the efficacy of supportive therapy versus habit-reversal therapy for the treatment of Tourette syndrome and chronic tic disorder.

What is the current status of trial NCT00231985?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 122 participants. The study started on 2005-10. Estimated completion is 2010-03.

What interventions are being tested in trial NCT00231985?

The interventions under investigation include: Supportive therapy (BEHAVIORAL), Habit reversal therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00231985?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.